FDA Yanks Ozone-Depleting Inhaler From Market
Primatene Mist, an epinephrine inhaler manufactured by Armstrong Pharmaceuticals Inc., will not be made or sold after Dec. 31, the FDA said. The product uses chlorofluorocarbons, or CFCs, to propel an asthma-relief medication out of the inhaler into a user's lungs.
The agency said it made the move in order...
To view the full article, register now.